David A. Cox

ORCID: 0000-0003-2052-9836 · 1 paper in corpus

rct 2011

Gynecologic effects of arzoxifene in postmenopausal women with osteoporosis or low bone mass

Menopause (New York, N.Y.) ·doi:10.1097/gme.0b013e318223bbf4

OBJECTIVE: The aim of this study was to report the gynecologic safety findings from the Generations trial, a phase 3 study of the selective estrogen receptor modulator (SERM), arzoxifene. METHODS: A predefined objective of the trial was to…